• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染者的 COVID-19 结局:洞察疫情变化。

COVID-19 outcomes in people living with HIV: Peering through the waves.

机构信息

Universidade Federal de São João del-Rei, Campus Centro Oeste Dona Lindu, Divinópolis, MG, Brazil; Instituto de Avaliação de Tecnologia em Saúde (IATS), Porto Alegre, RS, Brazil.

Department of Internal Medicine, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Clinics (Sao Paulo). 2023 May 25;78:100223. doi: 10.1016/j.clinsp.2023.100223. eCollection 2023.

DOI:10.1016/j.clinsp.2023.100223
PMID:37331214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10209448/
Abstract

OBJECTIVE

To evaluate clinical characteristics and outcomes of COVID-19 patients infected with HIV, and to compare with a paired sample without HIV infection.

METHODS

This is a substudy of a Brazilian multicentric cohort that comprised two periods (2020 and 2021). Data was obtained through the retrospective review of medical records. Primary outcomes were admission to the intensive care unit, invasive mechanical ventilation, and death. Patients with HIV and controls were matched for age, sex, number of comorbidities, and hospital of origin using the technique of propensity score matching (up to 4:1). They were compared using the Chi-Square or Fisher's Exact tests for categorical variables and the Wilcoxon for numerical variables.

RESULTS

Throughout the study, 17,101 COVID-19 patients were hospitalized, and 130 (0.76%) of those were infected with HIV. The median age was 54 (IQR: 43.0;64.0) years in 2020 and 53 (IQR: 46.0;63.5) years in 2021, with a predominance of females in both periods. People Living with HIV (PLHIV) and their controls showed similar prevalence for admission to the ICU and invasive mechanical ventilation requirement in the two periods, with no significant differences. In 2020, in-hospital mortality was higher in the PLHIV compared to the controls (27.9% vs. 17.7%; p = 0.049), but there was no difference in mortality between groups in 2021 (25.0% vs. 25.1%; p > 0.999).

CONCLUSIONS

Our results reiterate that PLHIV were at higher risk of COVID-19 mortality in the early stages of the pandemic, however, this finding did not sustain in 2021, when the mortality rate is similar to the control group.

摘要

目的

评估感染 HIV 的 COVID-19 患者的临床特征和结局,并与未感染 HIV 的配对样本进行比较。

方法

这是巴西多中心队列的一项子研究,该研究分为两个时期(2020 年和 2021 年)。数据通过回顾病历获得。主要结局为入住重症监护病房、接受有创机械通气和死亡。采用倾向评分匹配(最多 4:1)对 HIV 患者和对照组的年龄、性别、共病数量和来源医院进行匹配。使用卡方检验或 Fisher 精确检验比较分类变量,使用 Wilcoxon 检验比较数值变量。

结果

在整个研究过程中,共有 17101 例 COVID-19 患者住院,其中 130 例(0.76%)感染了 HIV。2020 年和 2021 年的中位年龄分别为 54(IQR:43.0;64.0)岁和 53(IQR:46.0;63.5)岁,两个时期均以女性为主。在两个时期,接受有创机械通气和入住 ICU 的 PLHIV 与对照组的发生率相似,无显著差异。2020 年,PLHIV 的住院死亡率高于对照组(27.9%比 17.7%;p=0.049),但 2021 年两组死亡率无差异(25.0%比 25.1%;p>0.999)。

结论

我们的结果再次表明,在大流行早期,PLHIV 感染 COVID-19 的死亡率较高,但这一发现并未在 2021 年持续,当时死亡率与对照组相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab5/10293664/32d410809548/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab5/10293664/32d410809548/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab5/10293664/32d410809548/gr1.jpg

相似文献

1
COVID-19 outcomes in people living with HIV: Peering through the waves.HIV 感染者的 COVID-19 结局:洞察疫情变化。
Clinics (Sao Paulo). 2023 May 25;78:100223. doi: 10.1016/j.clinsp.2023.100223. eCollection 2023.
2
Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.与 COVID-19 住院的 HIV 感染者的临床特征和结局:一项全国性经验。
Int J STD AIDS. 2021 Apr;32(5):435-443. doi: 10.1177/0956462420973106. Epub 2021 Feb 3.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.与 HIV 感染者 SARS-CoV-2 诊断和重症 COVID-19 结局相关的社会人口学、临床和免疫学因素:一项回顾性队列研究。
Lancet HIV. 2021 Nov;8(11):e701-e710. doi: 10.1016/S2352-3018(21)00240-X. Epub 2021 Oct 13.
5
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
6
Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda.在乌干达,与未合并感染艾滋病毒的新冠肺炎患者相比,感染艾滋病毒的新冠肺炎患者接受重症监护病房会诊的次数更多。
J Med Virol. 2022 Sep;94(9):4294-4300. doi: 10.1002/jmv.27887. Epub 2022 Jun 2.
7
Clinical outcomes of patients with COVID-19 and HIV coinfection.COVID-19 与 HIV 合并感染患者的临床结局。
J Med Virol. 2021 Mar;93(3):1687-1693. doi: 10.1002/jmv.26533. Epub 2020 Oct 14.
8
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
9
COVID-19 in people living with HIV: a single-center descriptive study.HIV 感染者中的 COVID-19:一项单中心描述性研究。
J Infect Dev Ctries. 2022 Dec 31;16(12):1796-1799. doi: 10.3855/jidc.16990.
10
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.意大利伦巴第地区 COVID-19 疫苗接种与入住重症监护病房以及 COVID-19 肺炎重症患者结局的相关性。
JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871.

引用本文的文献

1
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.新冠病毒仍是威胁吗?免疫功能低下个体持续的医疗负担专家意见综述。
Adv Ther. 2025 Feb;42(2):666-719. doi: 10.1007/s12325-024-03043-0. Epub 2024 Dec 16.
2
COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis.COVID-19 突破性感染在 HIV 感染者中的研究:全州队列分析。
J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):107-116. doi: 10.1097/QAI.0000000000003475.
3
Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.

本文引用的文献

1
SARS-CoV-2 uses CD4 to infect T helper lymphocytes.SARS-CoV-2 利用 CD4 感染辅助性 T 淋巴细胞。
Elife. 2023 Jul 31;12:e84790. doi: 10.7554/eLife.84790.
2
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19.HIV 感染者住院期间发生严重或致命 COVID-19 的临床特征和危险因素:对世卫组织全球 COVID-19 临床平台数据的分析。
Lancet HIV. 2022 Jul;9(7):e486-e495. doi: 10.1016/S2352-3018(22)00097-2. Epub 2022 May 10.
3
Global and Regional Prevalence and Outcomes of COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.
HIV 感染者感染 SARS-CoV-2 的临床结局和免疫反应。
Exp Biol Med (Maywood). 2024 Apr 2;249:10059. doi: 10.3389/ebm.2024.10059. eCollection 2024.
HIV感染者中COVID-19的全球和区域患病率及转归:一项系统评价和荟萃分析。
Trop Med Infect Dis. 2022 Feb 3;7(2):22. doi: 10.3390/tropicalmed7020022.
4
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis.HIV 和 COVID-19 合并感染患者的结局:系统评价和荟萃分析。
AIDS Res Ther. 2022 Jan 14;19(1):3. doi: 10.1186/s12981-021-00427-y.
5
HIV infection and increased risk of COVID-19 mortality: A Meta-Analysis.艾滋病毒感染与新冠病毒疾病死亡风险增加:一项荟萃分析
Eur J Transl Myol. 2021 Dec 21;31(4):10107. doi: 10.4081/ejtm.2021.10107.
6
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data.HIV 感染与 COVID-19 临床谱的相关性:基于美国国家 COVID 队列协作(N3C)数据的人群水平分析。
Lancet HIV. 2021 Nov;8(11):e690-e700. doi: 10.1016/S2352-3018(21)00239-3. Epub 2021 Oct 13.
7
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.与 HIV 感染者 SARS-CoV-2 诊断和重症 COVID-19 结局相关的社会人口学、临床和免疫学因素:一项回顾性队列研究。
Lancet HIV. 2021 Nov;8(11):e701-e710. doi: 10.1016/S2352-3018(21)00240-X. Epub 2021 Oct 13.
8
Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes.单细胞分析 COVID-19、脓毒症和 HIV 感染揭示了单核细胞中的过度炎症和免疫抑制特征。
Cell Rep. 2021 Oct 5;37(1):109793. doi: 10.1016/j.celrep.2021.109793. Epub 2021 Sep 17.
9
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.南非高 HIV 和结核病流行地区 COVID-19 相关住院死亡率的危险因素:一项队列研究。
Lancet HIV. 2021 Sep;8(9):e554-e567. doi: 10.1016/S2352-3018(21)00151-X. Epub 2021 Aug 4.
10
HIV infection and risk of COVID-19 mortality: A meta-analysis.HIV 感染与 COVID-19 死亡率风险:荟萃分析。
Medicine (Baltimore). 2021 Jul 2;100(26):e26573. doi: 10.1097/MD.0000000000026573.